GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

GSK plc

Turnover

Turnover %Chg

Turnover Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Selling, General and Administration

Selling, General and Administration %Chg

Selling, General and Administration Common Size

Research and Development

Research and Development %Chg

Research and Development Common Size

Royalty Income

Royalty Income %Chg

Royalty Income Common Size

Other Operating Expense

Other Operating Expense %Chg

Other Operating Expense Common Size

Other Operating Income

Other Operating Income %Chg

Other Operating Income Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Finance Income

Finance Income %Chg

Finance Income Common Size

Finance Costs

Finance Costs %Chg

Finance Costs Common Size

Share of After Tax Profits of Associates and Joint Ventures

Share of After Tax Profits of Associates and Joint Ventures %Chg

Share of After Tax Profits of Associates and Joint Ventures Common Size

Loss on Disposal of Interests in Associates

Loss on Disposal of Interests in Associates %Chg

Loss on Disposal of Interests in Associates Common Size

Profit Before Taxation

Profit Before Taxation %Chg

Profit Before Taxation Common Size

Taxation

Taxation %Chg

Taxation Common Size

Profit After Taxation for the Year

Profit After Taxation for the Year %Chg

Profit After Taxation for the Year Common Size

Profit After Taxation from Continuing Operations

Profit After Taxation from Continuing Operations %Chg

Profit After Taxation from Continuing Operations Common Size

Profit After Taxation from Discontinued Operations and Other Gains from the Demerger

Profit After Taxation from Discontinued Operations and Other Gains from the Demerger %Chg

Profit After Taxation from Discontinued Operations and Other Gains from the Demerger Common Size

Remeasurement of Discontinued Operations Distributed to Shareholders on Demerger

Remeasurement of Discontinued Operations Distributed to Shareholders on Demerger %Chg

Remeasurement of Discontinued Operations Distributed to Shareholders on Demerger Common Size

Profit After Taxation from Discontinued Operations

Profit After Taxation from Discontinued Operations %Chg

Profit After Taxation from Discontinued Operations Common Size

Total Profit After Taxation for the Year

Total Profit After Taxation for the Year %Chg

Total Profit After Taxation for the Year Common Size

Profit Attributable to Non-Controlling Interests from Continuing Operations

Profit Attributable to Non-Controlling Interests from Continuing Operations %Chg

Profit Attributable to Non-Controlling Interests from Continuing Operations Common Size

Profit Attributable to Shareholders from Continuing Operations

Profit Attributable to Shareholders from Continuing Operations %Chg

Profit Attributable to Shareholders from Continuing Operations Common Size

Profit Attributable to Non-Controlling Interests from Discontinued Operations

Profit Attributable to Non-Controlling Interests from Discontinued Operations %Chg

Profit Attributable to Non-Controlling Interests from Discontinued Operations Common Size

Profit Attributable to Shareholders from Discontinued Operations

Profit Attributable to Shareholders from Discontinued Operations %Chg

Profit Attributable to Shareholders from Discontinued Operations Common Size

Profit After Taxation

Profit After Taxation %Chg

Profit After Taxation Common Size

Total Profit Attributable to Non-Controlling Interests

Total Profit Attributable to Non-Controlling Interests %Chg

Total Profit Attributable to Non-Controlling Interests Common Size

Profit Attributable to Shareholders

Profit Attributable to Shareholders %Chg

Profit Attributable to Shareholders Common Size

Profit for the Year

Profit for the Year %Chg

Profit for the Year Common Size

Basic Earnings per Share from Continuing Operations

Basic Earnings per Share from Continuing Operations %Chg

Basic Earnings per Share from Continuing Operations Common Size

Basic Earnings per Share from Discontinued Operations

Basic Earnings per Share from Discontinued Operations %Chg

Basic Earnings per Share from Discontinued Operations Common Size

Total Basic Earnings per Share

Total Basic Earnings per Share %Chg

Total Basic Earnings per Share Common Size

Diluted Earnings per Share from Continuing Operations

Diluted Earnings per Share from Continuing Operations %Chg

Diluted Earnings per Share from Continuing Operations Common Size

Diluted Earnings per Share from Discontinued Operations

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Research & Development Expenses

Research & Development Expenses %Chg

Research & Development Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest and Investment Income

Interest and Investment Income %Chg

Interest and Investment Income Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Minority Interests and Other

Net Income Attributable to Minority Interests and Other %Chg

Net Income Attributable to Minority Interests and Other Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24
Total Revenues	31,631	31,529	31,376	31,311	31,446	30,740
Total Revenues %Chg	0.6%	2.6%	3.5%	5.6%	7.2%	5.7%
Turnover
Cost of Sales	9,058	9,015	9,048	8,907	8,782	8,592
Cost of Sales
Gross Profit	22,573	22,514	22,328	22,404	22,664	22,148
Gross Profit
Gross Profit Margin	71.4%	71.4%	71.2%	71.6%	72.1%	72%
Selling, General & Administrative Expenses	10,673	10,998	11,015	11,030	9,526	9,329
Selling, General and Administration
Research & Development Expenses	6,976	6,429	6,401	6,417	6,533	6,397
Research and Development
Other Operating Expenses	-200	340	891	1,059	947	269
Royalty Income
Other Operating Income
Other Operating Expense
Operating Profit	5,124	4,747	4,021	3,898	5,658	6,153
Operating Profit
Operating Margin	16.2%	15.1%	12.8%	12.4%	18%	20%
Interest and Investment Income	170	144	122	117	109	118
Finance Income
Interest Expense	-675	-665	-669	-718	-744	-755
Finance Costs
Non-Operating Income	-4	-3	1	-4	-3	-4
Share of After Tax Profits of Associates and Joint Ventures
Loss on Disposal of Interests in Associates
Total Non-Operating Income	-509	-524	-546	-605	-638	-641
Income Before Provision for Income Taxes	4,622	4,230	3,477	3,293	5,020	5,512
Profit Before Taxation
Provision for Income Taxes	638	588	526	445	703	754
Taxation
Consolidated Net Income	3,984	3,642	2,951	2,848	4,317	4,758
Profit for the Year
Net Income Attributable to Minority Interests and Other	561	489	376	337	284	274
Total Profit Attributable to Non-Controlling Interests
Net Income Attributable to Discontinued Operations	—	—	—	—	—	—
Profit After Taxation from Discontinued Operations
Net Income Attributable to Common Shareholders	3,423	3,153	2,575	2,511	4,033	4,484
Profit Attributable to Shareholders
Basic EPS	0.8	0.8	0.6	0.6	1	1.1
Diluted EPS	0.8	0.8	0.6	0.6	1	1.1
Basic Weighted Average Shares Outstanding	4,078.3	4,082.3	4,077	4,071	4,064.8	4,058.3
Total Shares Outstanding	4,089.2	4,127.9	4,314.3	4,080	4,079	4,078
Diluted Weighted Average Shares Outstanding	4,133	4,136	4,142	4,123	4,115.8	4,108.5
EBITDA	5,918	5,189	4,021	4,366	5,754	6,062
Effective Tax Rate	13.8%	13.9%	15.1%	13.5%	14%	13.7%